Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec 22:11:591407.
doi: 10.3389/fpsyt.2020.591407. eCollection 2020.

Dopamine Multilocus Genetic Profile, Spontaneous Activity of Left Superior Temporal Gyrus, and Early Therapeutic Effect in Major Depressive Disorder

Affiliations

Dopamine Multilocus Genetic Profile, Spontaneous Activity of Left Superior Temporal Gyrus, and Early Therapeutic Effect in Major Depressive Disorder

Xiaoyun Liu et al. Front Psychiatry. .

Abstract

Objectives: This study aimed to examine the interactive effects of dopamine (DA) pathway gene and disease on spontaneous brain activity and further to explore the relationship between spontaneous brain activity and the early antidepressant therapeutic effect in patients with major depressive disorder (MDD). Methods: A total of 104 patients with MDD and 64 healthy controls (HCs) were recruited. The Hamilton Depression Scale-24 (HAMD-24) was used to measure the depression severity. Both groups were given resting-state functional magnetic resonance imaging (rs-fMRI) scan. The amplitude of low-frequency fluctuation (ALFF) was calculated to reflect the spontaneous brain activity based on the rs-fMRI data. After treatment for 2 weeks, depression severity was evaluated again, and HAMD-24 reductive rate was used to measure the therapeutic effect of antidepressants. Multilocus genetic profile scores (MGPS) were used to assess the multi-site cumulative effect of DA pathway gene. The interactive effects of MDD and DA pathway gene on the ALFF of regional brain areas were measured by the multivariate linear regression analysis. Finally, partial correlation analysis (age, sex, education, and illness durations as covariates) was performed to identify the relationship between regional ALFF and therapeutic effect. Results: MDD and DA-MGPS had interactive effects on the left fusiform gyrus (FG_L), right calcarine sulcus (CS_R), left superior temporal gyrus (STG_L), bilateral cerebellum posterior lobe (CPL), bilateral inferior frontal gyrus (IFG), and bilateral superior frontal gyrus (SFG). Partial correlation analysis revealed that the ALFF of STG_L had a significant negative correlation with 2-week HAMD-24 reductive rate (r = -0.211, P = 0.035). Conclusions: The spontaneous activity of STG_L may be a potential biomarker of antidepressant-related early therapeutic effect underlying the influence of DA pathway genes in MDD.

Keywords: amplitude of low-frequency fluctuation; dopamine; early therapeutic effect; major depressive disorder; multilocus genetic profile scores.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The interactive brain areas of DA pathway gene and major depressive disorder. The colored bar indicated the display window for the threshold t-value maps. Hot color represented a higher ALFF value, while blue represented a lower ALFF value. FG_L, left fusiform gyrus; CPL_R, right cerebellum posterior lobe; STG_L, left superior temporal gyrus; CPL_L, left cerebellum posterior lobe; IFG_R, right inferior frontal gyrus; IFG_L, left inferior frontal gyrus; CS_R, right calcarine sulcus; SFG_L, left superior frontal gyrus; SFG_R, right superior frontal gyrus.
Figure 2
Figure 2
The STG_L ALFF had a negative correlation with 2-week HAMD reductive rate (r = −0.211, P = 0.035). ALFF_STG_L, the amplitude of low-frequency fluctuation of left superior temporal gyrus.

Similar articles

Cited by

References

    1. Badamasi IM, Lye MS, Ibrahim N, Stanslas J. Genetic endophenotypes for insomnia of major depressive disorder and treatment-induced insomnia. J Neural Trans. (2019) 126:711–22. 10.1007/s00702-019-02014-y - DOI - PubMed
    1. Guerrera CS, Furneri G, Grasso M, Caruso G, Castellano S, Drago F, et al. . Antidepressant drugs and physical activity: a possible synergism in the treatment of major depression? Front Psychol. (2020) 11:857. 10.3389/fpsyg.2020.00857 - DOI - PMC - PubMed
    1. Boylan K, MacQueen G, Kirkpatrick R, Lee JN, Santaguida PL. A systematic review of interventions for treatment resistant major depressive disorder in adolescents. Eur Child Adolesc Psychiatry. (2020) 29:433–43. 10.1007/s00787-019-01341-5 - DOI - PubMed
    1. Hou ZH, Kong YY, He XF, Yin YY, Zhang YQ, Yuan YG. Increased temporal variability of striatum region facilitating the early antidepressant response in patients with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. (2018) 85:39–45. 10.1016/j.pnpbp.2018.03.026 - DOI - PubMed
    1. Williams LM, Rush AJ, Koslow SH, Wisniewski SR, Cooper NJ, Nemeroff CB, et al. . International study to predict optimized treatment for depression (iSPOT-D), a randomized clinical trial: rationale and protocol. Trials. (2011) 12:4. 10.1186/1745-6215-12-4 - DOI - PMC - PubMed

LinkOut - more resources